In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
After finishing at $14.67 in the prior trading day, Invesco Ltd (NYSE: IVZ) closed at $14.46, down -1.43%. In other words, the price has decreased by -$1.43 from its previous closing price. On the day, 6.07 million shares were traded. IVZ stock price reached its highest trading level at $14.76 during the session, while it also had its lowest trading level at $14.3.
Ratios:
Our goal is to gain a better understanding of IVZ by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.56 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 5.69. In the meantime, Its Debt-to-Equity ratio is 0.59 whereas as Long-Term Debt/Eq ratio is at 0.59.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, TD Cowen on January 04, 2024, initiated with a Outperform rating and assigned the stock a target price of $21.
On December 14, 2023, Keefe Bruyette Upgraded its rating to Outperform which previously was Mkt Perform and also upped its target price recommendation from $15.50 to $20.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 02 ’23 when Invesco Realty, Inc. bought 796,323 shares for $25.12 per share. The transaction valued at 20,000,000 led to the insider holds 1,052,487 shares of the business.
Invesco Realty, Inc. bought 2,800,000 shares of IVZ for $70,000,000 on Sep 05 ’23. The 10% Owner now owns 853,400 shares after completing the transaction at $25.00 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IVZ now has a Market Capitalization of 6598560768 and an Enterprise Value of 8163908096. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.12 while its Price-to-Book (P/B) ratio in mrq is 0.45. Its current Enterprise Value per Revenue stands at 1.414 whereas that against EBITDA is 8.35.
Stock Price History:
The Beta on a monthly basis for IVZ is 1.43, which has changed by -0.119366646 over the last 52 weeks, in comparison to a change of 0.24191546 over the same period for the S&P500. Over the past 52 weeks, IVZ has reached a high of $18.71, while it has fallen to a 52-week low of $12.48. The 50-Day Moving Average of the stock is -7.72%, while the 200-Day Moving Average is calculated to be -6.72%.
Shares Statistics:
The stock has traded on average 4.58M shares per day over the past 3-months and 5378140 shares per day over the last 10 days, according to various share statistics. A total of 449.50M shares are outstanding, with a floating share count of 441.75M. Insiders hold about 1.66% of the company’s shares, while institutions hold 84.59% stake in the company. Shares short for IVZ as of 1713139200 were 12700430 with a Short Ratio of 2.77, compared to 1710460800 on 8044926. Therefore, it implies a Short% of Shares Outstanding of 12700430 and a Short% of Float of 4.7199998.
Dividends & Splits
In the trailing 12 months, IVZ’s forward annual dividend rate was 0.805, compared to 0.80 this year. Against a Trailing Annual Dividend Yield of 0.05487389The stock’s 5-year Average Dividend Yield is 5.39.
Earnings Estimates
Its stock is currently analyzed by 13.0 different market analysts. On average, analysts expect EPS of $0.41 for the current quarter, with a high estimate of $0.47 and a low estimate of $0.28, while EPS last year was $0.31. The consensus estimate for the next quarter is $0.43, with high estimates of $0.49 and low estimates of $0.34.
Analysts are recommending an EPS of between $1.95 and $1.32 for the fiscal current year, implying an average EPS of $1.64. EPS for the following year is $1.85, with 14.0 analysts recommending between $2.13 and $1.5.
Revenue Estimates
9 analysts predict $1.11B in revenue for the current quarter. It ranges from a high estimate of $1.16B to a low estimate of $1.07B. As of the current estimate, Invesco Ltd’s year-ago sales were $1.09BFor the next quarter, 9 analysts are estimating revenue of $1.11B. There is a high estimate of $1.16B for the next quarter, whereas the lowest estimate is $1.06B.
A total of 9 analysts have provided revenue estimates for IVZ’s current fiscal year. The highest revenue estimate was $4.65B, while the lowest revenue estimate was $4.3B, resulting in an average revenue estimate of $4.43B. In the same quarter a year ago, actual revenue was $4.31BBased on 9 analysts’ estimates, the company’s revenue will be $4.65B in the next fiscal year. The high estimate is $4.88B and the low estimate is $4.47B.
